Hughes Eric A
Insider CIK 1938678 · GLUE Director · TEVA See "Remarks"
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-08-03 | 2026-08-05 | 52,744 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-08-03 | 2026-08-05 | 25,578 | $34.88 | $892.2K | 134,877 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-08-03 | 2026-08-05 | 52,744 | — | $0 | 160,455 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-08-03 | 2026-08-05 | 52,744 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-08-03 | 2026-08-05 | 25,578 | $34.88 | $892.1K | 134,877 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-08-03 | 2026-08-05 | 52,744 | — | — | 160,455 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2026-06-11 | 2026-06-12 | 25,800 | — | $0 | 25,800 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-05 | 2026-03-09 | 19,654 | — | $0 | 58,962 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-05 | 2026-03-09 | 9,533 | $31.67 | $301.9K | 107,711 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-05 | 2026-03-09 | 19,654 | — | $0 | 117,244 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-03-04 | 2026-03-06 | 50,643 | — | $0 | 50,643 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-04 | 2026-03-06 | 23,251 | — | $0 | 46,503 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-04 | 2026-03-06 | 11,277 | $32.46 | $366.1K | 97,590 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-04 | 2026-03-06 | 23,251 | — | $0 | 108,867 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-03 | 2026-03-05 | 141,478 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-03 | 2026-03-05 | 24,900 | — | $0 | 24,901 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-03 | 2026-03-05 | 68,685 | $32.36 | $2.22M | 85,616 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-03 | 2026-03-05 | 24,900 | — | $0 | 24,900 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-03 | 2026-03-05 | 12,077 | $32.36 | $390.8K | 12,823 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-03 | 2026-03-05 | 141,478 | — | $0 | 154,301 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-01-27 | 2026-01-29 | 141,478 | — | $0 | 141,478 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-08-01 | 2025-08-05 | 52,742 | — | $0 | 52,744 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-08-01 | 2025-08-05 | 52,742 | — | $0 | 52,742 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-08-01 | 2025-08-05 | 52,742 | $15.16 | $799.6K | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2025-06-13 | 2025-06-16 | 30,700 | — | $0 | 30,700 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-03-05 | 2025-03-07 | 78,616 | — | $0 | 78,616 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-05 | 2025-03-06 | 8,077 | $15.91 | $128.5K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 23,251 | — | $0 | 69,754 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-04 | 2025-03-05 | 5,174 | $15.56 | $80.5K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 23,251 | — | $0 | 23,251 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-04 | 2025-03-06 | 15,174 | $15.73 | $238.7K | 8,077 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-03 | 2025-03-05 | 24,900 | — | $0 | 49,801 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-03 | 2025-03-05 | 24,900 | — | $0 | 24,900 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-03 | 2025-03-05 | 19,726 | $16.19 | $319.4K | 5,174 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-12-11 | 2024-12-13 | 44,200 | — | $0 | 44,200 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-08-09 | 2024-08-13 | 45,060 | $17.38 | $783.1K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-08-01 | 2024-08-05 | 52,742 | — | $0 | 105,486 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-08-01 | 2024-08-05 | 24,537 | $17.25 | $423.3K | 45,060 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-08-01 | 2024-08-05 | 52,742 | — | $0 | 69,597 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-03-04 | 2024-03-05 | 93,005 | — | $0 | 93,005 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-03-04 | 2024-03-05 | 8,045 | $13.34 | $107.3K | 16,855 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-03 | 2024-03-05 | 24,900 | — | $0 | 74,701 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-03 | 2024-03-05 | 24,900 | — | $0 | 24,900 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-08-01 | 2023-08-03 | 52,742 | — | $0 | 158,228 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-08-01 | 2023-08-03 | 52,742 | — | $0 | 52,742 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2023-08-01 | 2023-08-03 | 52,742 | $8.30 | $437.8K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-03-03 | 2023-03-07 | 99,601 | — | $0 | 99,601 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-08-01 | 2022-08-03 | 210,970 | — | $0 | 210,970 | SEC↗ |